CERES
CERES TEST Only!
  • Communities & Collections
  • Browse CERES
  • Library Staff Log In
    New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Pardakhty, Abbas"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    ItemOpen Access
    Multifunctional polymeric nanoplatforms for brain diseases diagnosis, therapy and theranostics
    (MDPI, 2020-01-13) Shakeri, Shahryar; Ashrafizadeh, Milad; Zarrabi, Ali; Roghanian, Rasoul; Afshar, Elham Ghasemipour; Pardakhty, Abbas; Mohammadinejad, Reza; Kumar, Anuj; Thakur, Vijay Kumar
    The blood–brain barrier (BBB) acts as a barrier to prevent the central nervous system (CNS) from damage by substances that originate from the blood circulation. The BBB limits drug penetration into the brain and is one of the major clinical obstacles to the treatment of CNS diseases. Nanotechnology-based delivery systems have been tested for overcoming this barrier and releasing related drugs into the brain matrix. In this review, nanoparticles (NPs) from simple to developed delivery systems are discussed for the delivery of a drug to the brain. This review particularly focuses on polymeric nanomaterials that have been used for CNS treatment. Polymeric NPs such as polylactide (PLA), poly (D, L-lactide-co-glycolide) (PLGA), poly (ε-caprolactone) (PCL), poly (alkyl cyanoacrylate) (PACA), human serum albumin (HSA), gelatin, and chitosan are discussed in detail.

Quick Links

  • About our Libraries
  • Cranfield Research Support
  • Cranfield University

Useful Links

  • Accessibility Statement
  • CERES Takedown Policy

Contacts-TwitterFacebookInstagramBlogs

Cranfield Campus
Cranfield, MK43 0AL
United Kingdom
T: +44 (0) 1234 750111
  • Cranfield University at Shrivenham
  • Shrivenham, SN6 8LA
  • United Kingdom
  • Email us: researchsupport@cranfield.ac.uk for REF Compliance or Open Access queries

Cranfield University copyright © 2002-2025
Cookie settings | Privacy policy | End User Agreement | Send Feedback